** Shares of disinfectant devices maker Nanosonics NAN.AX
soar as much as 14.4% to A$3.090
** Co
reports
FY net profit after tax of A$13 mln ($8.8 mln), beating a
Visible Alpha consensus of A$9.3 mln
** Co says FY NPAT down 35% from prior corresponding period
due to impact of hospital capital budget constraints
** NAN's annual revenue was at A$170 mln and co forecasts
FY25 revenue growth of 8%-12%
** Stock on track to end the month with a loss after
gaining ~12% in the last two months
** NAN has fallen ~38.6% YTD, as of last close
($1 = 1.4758 Australian dollars)
(Reporting by Archishma Iyer)
((Archishma.Iyer@thomsonreuters.com;))